home / press / releases

Menu
  • Search all tables

releases: https://davids.house.gov/media/press-releases/house-passes-davids-backed-legislation-lower-cost-prescription-drugs

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url title date year month party chamber state member_name bioguide_id domain scraper source date_source text has_text collected_at updated_at
https://davids.house.gov/media/press-releases/house-passes-davids-backed-legislation-lower-cost-prescription-drugs House Passes Davids-Backed Legislation to Lower the Cost of Prescription Drugs 2019-12-12 2019 2019-12 Democrat House KS Sharice Davids D000629 davids.house.gov     legacy Today, Representative ShariceDavidsvoted to pass transformational legislation to lower the cost of prescription drugs for families across Kansas' Third District. The Lower Drug Costs Now Act, H.R. 3,gives Medicare the power to negotiate with drug companies for lower drug prices, and makes those lower prices available even to those with private insurance. WhenKansansgo to the pharmacy to pick up their medication, they deserve a fair deal on their drug prices,Davidssaid.This legislation will lower costs for Kansans and stop drug companies from gouging consumers, while saving patients and taxpayers hundreds of billions of dollars over the next few years.I was proud to join my House colleagues in passing this critical piece of legislation, and now it's time for theSenate to finally stand up to Big Pharma and do the same. Non-partisan analysis from the Congressional Budget Office found that this legislation will save taxpayers$456billionin Medicare Part D Spending from 2023-2029. The Office of the Actuary found that it will save households $158 billion and private businesses $46 billion from 2020-2029. H.R. 3,The Lower Drug Costs Now Act: Gives Medicare the power to negotiate directly with drug companies for lower drug prices, while ensuring seniors never lose access to the prescriptions they need. Makes the lower drug prices negotiated byMedicare available to Americanswith private insurance,not just Medicare beneficiaries. Stops drug companies from charging Americans double and triple the pricefor the same medication as people in other countries pay. Creates a new, $2,000 out-of-pocket limit on prescription drug costs for Medicare beneficiaries, and stops unfair price hikes for thousands of medications, including insulin. Reinvests inthe biggestimprovementsto Medicare since its creation delivering vision, dental and hearing benefits andacceleratingthe search for new cures. 1 2026-03-30T12:14:52Z 2026-03-30T12:14:52Z
Powered by Datasette · Queries took 1.579ms · Data license: MIT · Data source: dwillis/congress-press